Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/698209


France In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012


Description: France In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the France In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in France

Scope

-The report provides in vitro diagnostics information broken down into detailed categories and segments in France.
-Total revenues, end users
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.


Reasons to buy

-Gain a strong understanding of the in vitro diagnostics devices market in France.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
-Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1 Table Of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets Covered in the Report 14
3.1 In Vitro Diagnostics Devices 14
3.2 Clinical Chemistry Test Reagents 14
3.2.1 Laboratory Reagents 14
3.2.2 Clinical Chemistry Calibrators and Controls 14
3.2.3 Clinical Chemistry Rapid Tests 14
3.3 Immunochemistry Test Reagents 14
3.3.1 Disease Specific Markers 14
3.3.2 Disease Specific Test Reagents 15
3.3.3 Drug Related Testing Reagents 15
3.3.4 Hormone Related Testing Reagents 16
3.3.5 Immunochemistry Calibrators and Controls 16
3.3.6 Immunochemistry Rapid Tests 16
3.4 Blood Test Reagents 16
3.4.1 Hematology Test Reagents 17
3.4.2 Hemostasis Test Reagents 17
3.4.3 Tissue Typing Reagents 18
3.4.4 Monoclonal Antibodies 18
3.4.5 Cytokines and Immunomodulators 18
3.4.6 Histology and Cytology Reagents 18
3.5 Microbiology Test Reagents 18
3.5.1 Bacteriology Test Reagents 18
3.5.2 Microbiology Calibrators and Controls 19
3.5.3 Microbiology Rapid Tests 19
3.6 Infectious Immunology Test Reagents 19
3.6.1 Bacteriology 19
3.6.2 Virology 19
3.6.3 Parasitology 19
3.6.4 Infectious Immunology Calibrators and Controls 19
3.6.5 Infectious Immunology Rapid Tests 19
3.7 Genetic Test Reagents 20
3.8 Self Testing 20
3.9 Instruments 20
4 Healthcare Sector Review 21
4.1 Healthcare Sector Review 21
4.2 Healthcare Expenditure 21
4.3 Healthcare Infrastructure 23
4.3.1 Healthcare Personnel Data 24
4.3.2 Healthcare Facilities Data 25
4.4 Healthcare Policy 26
5 Regulation System 27
5.1 Medical Equipment Approval Process 27
5.1.1 Classification 28
5.1.2 Conformity Assessment Process 36
5.1.3 Registration Fee 40
5.1.4 Registration Period 40
5.2 Post Market Surveillance (PMS) 41
6 Pricing and Reimbursement 42
6.1 Pricing and Reimbursement Policies 42
7 Distribution Structure 43
7.1 France Medical Equipment Distribution Structure 43
8 In Vitro Diagnostics In France 44
8.1 In Vitro Diagnostics Cross Country Comparison (2000-2012) 44
8.2 In Vitro Diagnostics, France, Overall Revenues ($ mn), 2000-2012 45
8.3 In Vitro Diagnostics, France Company share (2006-2007) 51
9 Blood Test Reagents In France 52
9.1 Blood Test Reagents Overall Revenue (2000-2012) 52
9.1.1 Haematology Test Reagents Revenue (2000-2012) 56
9.1.2 Hemostasis Test Reagents Revenue (2000-2012) 58
9.2 Blood Test Reagents Distribution Share (2006-2007) 60
9.3 Blood Test Reagents, France, Company Share (2006-2007) 61
10 Clinical Chemistry Test Reagents In France 62
10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012) 62
10.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007) 64
10.3 Clinical Chemistry Test Reagents, France, Company Share (2006-2007) 65
11 Genetic Test Reagents In France 66
11.1 Genetic Test Reagents Overall Revenue (2000-2012) 66
11.2 Genetic Test Reagents Distribution Share (2006-2007) 68
11.3 Genetic Test Reagents, France, Company Share (2006-2007) 69
12 Immunochemistry Test Reagents In France 70
12.1 Immunochemistry Test Reagents Overall Revenue (2000-2012) 70
12.1.1 Disease Specific Markers Revenue (2000-2012) 74
12.1.2 Disease Specific Test Reagents Revenue (2000-2012) 76
12.1.3 Drug Related Testing Reagents Revenue (2000-2012) 78
12.1.4 Hormone Related Testing Reagents Revenue (2000-2012) 80
12.2 Immunochemistry Test Reagents Distribution Share (2006-2007) 82
12.3 Immunochemistry Test Reagents, France, Company Share (2006-2007) 83
13 Infectious Immunology Test Reagents In France 84
13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012) 84
13.1.1 Virology Revenue (2000-2012) 88
13.2 Infectious Immunology Test Reagents Distribution Share (2006-2007) 90
13.3 Infectious Immunology Test Reagents, France, Company Share (2006-2007) 91
14 Instruments In France 92
14.1 Instruments Overall Revenue (2000-2012) 92
14.2 Instruments Distribution Share (2006-2007) 94
15 Microbiology Test Reagents In France 95
15.1 Microbiology Test Reagents Overall Revenue (2000-2012) 95
15.1.1 Bacteriology Test Reagents Revenue (2000-2012) 97
15.2 Microbiology Test Reagents Distribution Share (2006-2007) 99
15.3 Microbiology Test Reagents, France, Company Share (2006-2007) 100
16 Self Testing In France 101
16.1 Self Testing Overall Revenue (2000-2012) 101
16.2 Self Testing Distribution Share (2006-2007) 103
16.3 Self Testing, France, Company Share (2006-2007) 104
17 F. Hoffmann-La Roche Ltd. Company Profile 105
17.1 Company Overview 105
17.2 Value Chain Analysis 106
17.2.1 Manufacturing 106
17.2.2 Product Development 107
17.2.3 Sales and Marketing 108
18 Abbott Laboratories Company Profile 109
18.1 Company Overview 109
18.2 Value Chain Analysis 110
18.2.1 Manufacturing 110
18.2.2 Product Development 110
18.2.3 Sales and Marketing 112
19 Dade Behring Holdings, Inc. Company Profile 113
19.1 Company Overview 113
19.2 Dade Behring Holdings, Inc. Pipeline Products 113
19.2.1 Dade Behring Holdings, Inc. Pipeline Products By Equipment Type 113
19.2.2 Dade Behring Holdings, Inc. Pipeline Products By Development Stage 113
19.2.3 Dade Behring Holdings, Inc. Pipeline Products By Therapy Area 113
19.2.4 Dade Behring Holdings, Inc. Pipeline Products By News Summary 113
20 bioMerieux S.A. Company Profile 114
20.1 Company Overview 114
20.2 Value Chain Analysis 115
20.2.1 Manufacturing 115
20.2.2 Product Development 116
20.2.3 Sales and Marketing 116
21 Beckman Coulter, Inc. Company Profile 118
21.1 Company Overview 118
21.2 Value Chain Analysis 119
21.2.1 Manufacturing 119
21.2.2 Product Development 119
21.2.3 Sales and Marketing 120
21.3 Beckman Coulter, Inc. Pipeline Products 121
21.3.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type 121
21.3.2 Beckman Coulter, Inc. Pipeline Products By Development Stage 122
21.3.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area 123
21.3.4 Beckman Coulter, Inc. Pipeline Products By News Summary 123
22 Siemens Medical Solutions Company Profile 124
22.1 Company Overview 124
22.2 Value Chain Analysis 125
22.2.1 Manufacturing 125
22.2.2 Product Development 125
22.2.3 Sales and Marketing 126
22.3 Siemens Medical Solutions Pipeline Products 127
22.3.1 Siemens Medical Solutions Pipeline Products By Equipment Type 127
22.3.2 Siemens Medical Solutions Pipeline Products By Development Stage 127
22.3.3 Siemens Medical Solutions Pipeline Products By Therapy Area 128
22.3.4 Siemens Medical Solutions Pipeline Products By News Summary 128
23 Argene S.A. Company Profile 129
23.1 Company Overview 129
24 EUROMEDEX Company Profile 130
24.1 Company Overview 130
25 ExonHit Therapeutics SA Company Profile 131
25.1 Company Overview 131
25.2 ExonHit Therapeutics SA Pipeline Products 131
25.2.1 ExonHit Therapeutics SA Pipeline Products By Equipment Type 131
25.2.2 ExonHit Therapeutics SA Pipeline Products By Development Stage 131
25.2.3 ExonHit Therapeutics SA Pipeline Products By Therapy Area 132
25.2.4 ExonHit Therapeutics SA Pipeline Products By News Summary 132
26 GEMAC S.A. Company Profile 133
26.1 Company Overview 133
27 Hemosystem Company Profile 134
27.1 Company Overview 134
28 Imaxio Company Profile 135
28.1 Company Overview 135
29 Laboratoires NEPHROTEK Company Profile 136
29.1 Company Overview 136
30 Financial Deals Landscape 137
30.1 Venture Financing 137
30.1.1 Genomic Vision Secures $6.3 Million In Series B Financing 137
30.2 Partnerships 138
30.2.1 Agendia Signs An Agreement With Ferrer inCode 138
31 Recent Developments 139
31.1 Legal and Regulatory 139
31.1.1 May 15, 2008: bioMerieux And FIND Signs MOU 139
32 Appendix 140
32.1 Global Markets Direct Research Methodology 140
32.2 Coverage 141
32.3 Secondary Research 141
32.4 Primary Research 142
32.5 Models 142
32.6 Forecasts 143
32.7 Expert Panels 143
32.8 Currency Conversion 144
32.9 Contact Us 145
32.10 Disclaimer 145

Executive Summary

1.1 List of Tables
Table 1: Number of Doctors by Specialty in France, 2003-2007 24
Table 2: Number of Hospital Wards by Specialty in France, 2003-2007 25
Table 3: In Vitro Diagnostics Cross Country Comparison (2000-2012) 44
Table 4: In Vitro Diagnostics, France, Overall Revenues ($ mn), 2000-2012 45
Table 5: In Vitro Diagnostics, France, Portfolio Analysis, 2000-2012 46
Table 6: In Vitro Diagnostics, France, Overall Revenues ($ mn), Historic, 2000-2007 48
Table 7: In Vitro Diagnostics, France, Overall Revenues ($ mn), Forecast, 2007-2012 50
Table 8: In Vitro Diagnostics, France Company share by Revenue ($ mn), 2006-2007 51
Table 9: Blood Test Reagents, France, Revenue ($ mn) by Segment , Historic, 2000-2007 53
Table 10: Blood Test Reagents, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 55
Table 11: Haematology Test Reagents, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 56
Table 12: Haematology Test Reagents, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 57
Table 13: Hemostasis Test Reagents, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 58
Table 14: Hemostasis Test Reagents, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 59
Table 15: Blood Test Reagents, France, Distribution Share by Revenue ($mn), 2006-2007 60
Table 16: Blood Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007 61
Table 17: Clinical Chemistry Test Reagents, France, Revenue ($ mn) by Segment , Historic, 2000-2007 62
Table 18: Clinical Chemistry Test Reagents, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 63
Table 19: Clinical Chemistry Test Reagents, France, Distribution Share by Revenue ($mn), 2006-2007 64
Table 20: Clinical Chemistry Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007 65
Table 21: Genetic Test Reagents, France, Revenue ($ mn) by Segment , Historic, 2000-2007 66
Table 22: Genetic Test Reagents, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 67
Table 23: Genetic Test Reagents, France, Distribution Share by Revenue ($mn), 2006-2007 68
Table 24: Genetic Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007 69
Table 25: Immunochemistry Test Reagents, France, Revenue ($ mn) by Segment , Historic, 2000-2007 71
Table 26: Immunochemistry Test Reagents, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 73
Table 27: Disease Specific Markers, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 74
Table 28: Disease Specific Markers, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 75
Table 29: Disease Specific Test Reagents, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 76
Table 30: Disease Specific Test Reagents, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 77
Table 31: Drug Related Testing Reagents, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 78
Table 32: Drug Related Testing Reagents, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 79
Table 33: Hormone Related Testing Reagents, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 80
Table 34: Hormone Related Testing Reagents, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 81
Table 35: Immunochemistry Test Reagents, France, Distribution Share by Revenue ($mn), 2006-2007 82
Table 36: Immunochemistry Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007 83
Table 37: Infectious Immunology Test Reagents, France, Revenue ($ mn) by Segment , Historic, 2000-2007 85
Table 38: Infectious Immunology Test Reagents, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 87
Table 39: Virology, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 88
Table 40: Virology, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 89
Table 41: Infectious Immunology Test Reagents, France, Distribution Share by Revenue ($mn), 2006-2007 90
Table 42: Infectious Immunology Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007 91
Table 43: Instruments, France, Revenue ($ mn) by Segment , Historic, 2000-2007 92
Table 44: Instruments, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 93
Table 45: Instruments, France, Distribution Share by Revenue ($mn), 2006-2007 94
Table 46: Microbiology Test Reagents, France, Revenue ($ mn) by Segment , Historic, 2000-2007 95
Table 47: Microbiology Test Reagents, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 96
Table 48: Bacteriology Test Reagents, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 97
Table 49: Bacteriology Test Reagents, France, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 98
Table 50: Microbiology Test Reagents, France, Distribution Share by Revenue ($mn), 2006-2007 99
Table 51: Microbiology Test Reagents, France, Company Share by Revenue ($ mn), 2006-2007 100
Table 52: Self Testing, France, Revenue ($ mn) by Segment , Historic, 2000-2007 101
Table 53: Self Testing, France, Revenue ($ mn) by Segment , Forecast, 2007-2012 102
Table 54: Self Testing, France, Distribution Share by Revenue ($mn), 2006-2007 103
Table 55: Self Testing, France, Company Share by Revenue ($ mn), 2006-2007 104
Table 56: Dade Behring Holdings, Inc. Pipeline Products by Equipment Type 113
Table 57: Dade Behring Holdings, Inc. Pipeline Products by Development Stage 113
Table 58: Dade Behring Holdings, Inc. Pipeline Products By Therapy Area 113
Table 59: Dade Behring Holdings, Inc. Pipeline Products By News Summaries 113
Table 60: Beckman Coulter, Inc. Pipeline Products by Equipment Type 121
Table 61: Beckman Coulter, Inc. Pipeline Products By Development Stage 122
Table 62: Beckman Coulter, Inc. Pipeline Products By Therapy Area 123
Table 63: Beckman Coulter, Inc. Pipeline Products By News Summaries 123
Table 64: Siemens Medical Solutions Pipeline Products by Equipment Type 127
Table 65: Siemens Medical Solutions Pipeline Products By Development Stage 127
Table 66: Siemens Medical Solutions Pipeline Products By Therapy Area 128
Table 67: Siemens Medical Solutions Pipeline Products By News Summaries 128
Table 68: ExonHit Therapeutics SA Pipeline Products by Equipment Type 131
Table 69: ExonHit Therapeutics SA Pipeline Products By Development Stage 131
Table 70: ExonHit Therapeutics SA Pipeline Products By Therapy Area 132
Table 71: ExonHit Therapeutics SA Pipeline Products By News Summaries 132
Table 72: Genomic Vision Secures $6.3 Million In Series B Financing 137
Table 73: Agendia Signs An Agreement With Ferrer inCode 138
Table 74: Currency Conversion from USD to Local Currency at 2007 Constant Rate 144


Companies Mentioned F. Hoffmann-La Roche Ltd. Abbott Laboratories Dade Behring Holdings, Inc. bioMerieux S.A. Beckman Coulter, Inc. Siemens Medical Solutions Argene S.A. EUROMEDEX ExonHit Therapeutics SA GEMAC S.A. Hemosystem Imaxio Laboratoires NEPHROTEK


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/698209

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/02/2012 01:43:52
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
France In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
Web Address:
http://www.researchandmarkets.com/reports/698209
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €2,263.00
Electronic (PDF) - Site License €4,527.00
Electronic (PDF) - Enterprisewide €6,790.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 16/02/2012 01:43:52

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)